Molecularly targeted therapy for hepatocellular carcinoma from the basic and clinical aspects
โ Scribed by Shigeki Arii
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 64 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1341-9625
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
For an approach of gene therapy for hepatocellular carcinoma (HCC), transcriptional regulatory sequence (TRS) of either alpha-fetoprotein (AFP) or albumin has been used for targeting cancer cells. To examine the feasibility of using TRSs of these genes for possible gene therapy of HCCs, the cellular
The dropout from the waiting list for liver transplantation among patients with hepatocellular carcinoma (HCC) is reportedly as high as 12% to 40% per year, mostly due to tumor progression. Considering the scarcity of donor organs, it would be beneficial if we could retain them within the Milan crit